Ripple Wins Wall Street Business With Brevan Howard Deal

Ripple Prime will provide multi-asset brokerage, clearing and financing services to Brevan Howard funds, expanding its work with institutional investors.

Study Says OpenAI’s Subscription Offers Less Value Than Claude’s

The Register reports a study favored Claude over OpenAI on subscription value, but the study, methods and plans compared are not identified.

Thinking Of Leaving Claude? Consider These Switching Costs

A report says Meta and Microsoft reduced internal Claude use. Their alternatives show why switching models can cost enterprises more than tokens.

OpenAI’s 722 AI Mathematics Proofs Prompt A Question About What’s Next

OpenAI says an unreleased model produced 722 mathematical manuscripts. Outside mathematicians have not yet confirmed the claimed results.

AI Made B2B Fraud Cheap And Trust Expensive

A PYMNTS interview with Bottomline’s Katie Elliott examines how AI is scaling fraud attempts and shifting supplier verification toward shared payment infrastructure.

How To Find An AI Meeting Note Taker: 15 Options For 2027

A 2027 buyer’s guide to 15 AI meeting note-taking options, with caveats on workflows, subscriptions, battery claims and privacy details.

U.S.–Belgium Trade Watch: Supply-Chain Operations And Trends

IdeaNavigator AI proposes testing a role-focused U.S.–Belgium trade monitor, but the 88/100 Trends signal has no stated scale or evidence of demand.

Vacant Storefronts, Meet Businesses Looking For A Place To Grow

A proposed marketplace would connect small-town storefront owners with businesses seeking space, with a five-town pilot measuring inquiries and leases.

Mistral Large 4’S Place In Today’s AI Frontier Race

Mistral released Large 4 in API preview. A benchmark snapshot puts it behind leading U.S. and Chinese models; its weights are not yet public.

Where Mistral Large 4 Shines—and Why It May Not Suit Your Agents

Mistral Large 4 marks a major score increase, but benchmark results, cost and reported hallucinations raise questions for agent use.